Laxmi Dental Ltd (LAXMIDENTL) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Laxmi Dental Ltd on NSE and BSE, with an AI summary of each filing.
Kids-e-Dental LLP ("KED"), a jointly controlled entity of the Company in which the Company holds 60% interest, has today, i.e. November 4, 2026, received the EU Quality Management System ....
Others (Uncategorized) · 05 Nov 2026, 3:15 am
Laxmi Dental Joint Venture Secures EU MDR and ISO Certifications Laxmi Dental Limited announced that its 60%-owned joint venture, Kids-e-Dental LLP (KED), received EU Quality Management System Certification under Regulation (EU) 2017/745 (valid 4th Nov'26 to 3rd Nov'31) and ISO 13485:2016 certification (valid until 3rd Nov'29) from TÜV SÜD. The approvals cover Class IIa non-active dental implants and materials, including E-iodocal, E-MTA variants, Bioflx crown, Kids-e-crown, and Kids-e-SSC. These certifications position KED to commercialize its dental products across the European Union and European Economic Area post-regulatory formalities.
Earnings Conference Call Recordings
Audio / Video · 04 Nov 2026, 9:13 pm
Laxmi Dental Releases Q2FY27 and H1FY27 Earnings Conference Call Audio Recording Laxmi Dental Limited has made available the audio recording of its Q2FY27 and H1FY27 earnings conference call held on 4th Nov'26 at 10:00 AM IST. Pursuant to Regulation 30(6) of SEBI Listing Regulations, the recording has been uploaded to the company's official website for investor access.
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release · 04 Nov 2026, 1:51 am
Laxmi Dental Reports Strong Q2FY27 Results with 38.5% YoY EBITDA Growth Laxmi Dental posted highest-ever quarterly consolidated revenue of INR 795.2 Mn for Q2FY27, up 10.0% YoY and 6.5% QoQ. EBITDA surged 38.5% YoY to INR 152.7 Mn, with margins expanding 390 bps YoY to 19.2%. Net profit rose 17.6% YoY to INR 100.4 Mn, though down 2.7% QoQ. Growth was driven by dental laboratory (+22.7% YoY) and aligner solutions (+23.5% YoY), while gross margins improved to 76.9%. Shareholders approved redeploying INR 48.1 Cr unutilized IPO proceeds, including INR 26.9 Cr for an integrated lab and aligner facility.
Earnings call Presentation
Investor Presentation · 04 Nov 2026, 1:42 am
Laxmi Dental Q2FY27 Results: Record Revenue and Strong EBITDA Margin Expansion Laxmi Dental reported record quarterly revenue from operations of INR 795.2 mn in Q2FY27, rising 10.0% YoY and 6.5% QoQ, driving H1FY27 revenue to INR 1,542.2 mn (+11.9% YoY). Core growth was led by dental laboratory (+22.7% YoY) and aligner solutions (+23.5% YoY), while scanner sales contracted to INR 35 mn. Q2FY27 EBITDA grew 38.5% YoY to INR 152.7 mn, with margins expanding 390 bps YoY to 19.2%. Consolidated PAT rose 17.6% YoY to INR 100.4 mn. Shareholders approved redeploying INR 481 mn unutilised IPO proceeds into integrated manufacturing facilities.
Laxmi Dental Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.
Outcome · 04 Nov 2026, 1:28 am
Financial Results For The Quarter And Half Year Ended September 30, 2026
Financial Result · 04 Nov 2026, 1:22 am
Laxmi Dental Q2 FY27 Consolidated Financial Results Laxmi Dental reported consolidated revenue from operations of INR 795.21 million for Q2 ended 30th Sep'26, up 10.04% YoY and 6.46% QoQ. Consolidated net profit reached INR 100.36 million, growing 17.63% YoY but declining 2.70% QoQ, with Basic EPS at INR 1.82. In H1FY27, revenue rose 11.86% YoY to INR 1,542.17 million, while net profit grew 20.69% YoY to INR 203.51 million. Segment-wise, Aligners posted strong Q2 EBIT growth of 91.69% YoY to INR 74.05 million. Unutilised IPO proceeds stood at INR 467.60 million.
Outcome of Board Meeting of Laxmi Dental Limited held on Tuesday, November 03, 2026 for approval of un-audited financial results (consolidated and standalone) for the quarter and half year ....
Outcome · 04 Nov 2026, 12:56 am
Laxmi Dental Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Million) ■ Revenue: 795 (+10.0% YoY | +6.5% QoQ) ■ EBITDA: 153 (+38.5% YoY | +6.3% QoQ) ■ EBITDA Margin (%): 19.2 (+394 bps YoY | -3 bps QoQ) ■ PAT: 100 (+17.6% YoY | -2.6% QoQ) ■ EPS (INR): 1.82 (+15.2% YoY | -2.7% QoQ) Laxmi Dental Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Million) Segmental Performance Laboratory business ■ Revenue: 542 (+8.4% YoY | +7.7% QoQ) ■ EBIT: 77.2 (+4.7% YoY | +0.3% QoQ) ■ EBIT Margin (%): 14.3 (-50 bps YoY | -105 bps QoQ) Aligners business ■ Revenue: 255 (+25.2% YoY | +5.5% QoQ) ■ EBIT: 74.1 (+91.7% YoY | +13.3% QoQ) ■ EBIT Margin (%): 29.0 (+1007 bps YoY | +201 bps QoQ) Other business ■ Revenue: 10.8 (-55.4% YoY | +3.5% QoQ) ■ EBIT: 1.4 (Loss to Profit YoY | +3.0% QoQ) ■ EBIT Margin (%): 12.6 (Loss to Profit YoY | -6 bps QoQ)
Intimation of Schedule of Analyst/ Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 to be held on 04th November, 2026.
Intimation · 04 Nov 2026, 10:00 am
Laxmi Dental Schedules Q2 and H1 FY27 Earnings Call on 4th Nov'26 Laxmi Dental Limited has scheduled its Q2FY27 and H1FY27 earnings conference call for Wednesday, 4th Nov'26, at 10:00 AM IST to discuss standalone and consolidated unaudited financial results for the period ended 30th Sep'26. Senior management participating in the call includes Chairperson and Whole-Time Director Rajesh Khakhar, MD and CEO Sameer Merchant, and CFO Dharmesh Dattani.
To consider and approve the financial results for the period ended September 30, 2026
Intimation · 03 Nov 2026, 5:30 am
Laxmi Dental Limited has informed the Exchange about Board Meeting to be held on 03-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2026 .
Intimation · 03 Nov 2026, 5:30 am
Laxmi Dental Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2026 ,inter alia, to consider and approve Laxmi Dental Limited has informed ....
Intimation · 03 Nov 2026, 5:30 am
Laxmi Dental Schedules Board Meeting for Q2 FY27 Financial Results Laxmi Dental Limited will convene its Board of Directors meeting on 3rd Nov'26 to consider and approve the unaudited standalone and consolidated financial results for the quarter and half-year ended 30th Sep'26. Additionally, the trading window for dealing in company securities, closed since 1st Oct'26 for designated persons and immediate relatives, will reopen 48 hours following the declaration of the results.
Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Others (Uncategorized) · 22 Oct 2026, 12:55 am
Laxmi Dental Announces Incorporation of Leelaben Foundation Under Section 8 Laxmi Dental Limited announced that the Ministry of Corporate Affairs has issued the Certificate of Incorporation and license under Section 8(1) of the Companies Act, 2013, for Leelaben Foundation, dated 21st Oct'26. Following prior board approval on 8th Oct'26 for the company to become a member, the non-profit entity limited by guarantee has been formally incorporated with its registered office situated in Mumbai, Maharashtra.
Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Others (Uncategorized) · 22 Oct 2026, 12:51 am
Laxmi Dental's US Subsidiary Receives US$ 0.63 Million Tariff Refund Laxmi Dental Limited announced on 21st Oct'26 that its US-based subsidiary, Laxmi Dental Lab USA, INC, received a tariff refund of US$ 0.63 million (~INR 59.20 million) from U.S. Customs and Border Protection (CBP). The refund follows US Supreme Court directives mandating the US Government to return excess tariffs collected from importers.
Intimation of Schedule of Analyst/ Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 to be held on 15th October, 2026.
Intimation · 10 Oct 2026, 4:32 pm
Laxmi Dental Schedules Analyst and Institutional Investor Group Meeting Laxmi Dental Limited has scheduled an in-person group interaction with analysts and institutional investors on 15th Oct'26 from 10:00 AM onwards. The meeting will take place at the company's manufacturing facilities situated within the Mumbai Metropolitan Region. Management stated that discussions will strictly adhere to publicly available information, with no unpublished price-sensitive information (UPSI) being shared.
Intimation of Monitoring Agency Report for the quarter ended September 30, 2026.
Others (Uncategorized) · 09 Oct 2026, 1:24 am
Laxmi Dental Limited: Q2 FY27 Monitoring Agency Report on IPO Proceeds Utilization ICRA reported no material deviations in Laxmi Dental's IPO proceeds utilization for the quarter ended 30th Sep'26. Out of total gross proceeds of INR 138.000 Cr, the company utilized INR 91.240 Cr cumulative to date, including INR 3.438 Cr during Q2 FY27. Unutilized proceeds of INR 46.760 Cr remain deployed in bank fixed deposits totaling INR 47.799 Cr. Shareholders approved fund deployment adjustments at the AGM on 25th Sep'26, reallocating Capex toward manufacturing infrastructure and movable assets.
Board comments on fine levied by BSE and NSE for delay in compliance under Regulation 29 of Listing Regulations.
Others (Uncategorized) · 09 Oct 2026, 12:11 am
Laxmi Dental Approves Non-Profit Membership and Addresses Exchange Penalties Laxmi Dental Limited's Board approved joining Leelaben Foundation, a proposed Section 8 non-profit company focused on rural dental facilities and CSR initiatives, holding a 10% guarantee control with a maximum liability commitment of up to INR 1,000. Additionally, the Board reviewed notices from BSE and NSE regarding delayed compliance with Regulation 29 for the quarter ended Jun'26. The delay was attributed to an oversight over the 8th–9th Aug'26 weekend. The company confirmed payment of the prescribed INR 11,800 fine (inclusive of 18% GST) per exchange.
Board of Directors of the Company, at its meeting held today, i.e., Thursday, October 08, 2026, has, inter alia, considered and approved the proposal for the Company to become a member ....
Others (Uncategorized) · 09 Oct 2026, 12:00 am
Laxmi Dental Approves Non-Profit Membership and Settles Exchange Penalties Laxmi Dental's Board approved joining Leelaben Foundation, a proposed Section 8 non-profit entity focused on rural dental healthcare, subsidized treatments, and CSR initiatives. The company holds 10% guarantee control with a maximum liability contribution of INR 1,000 upon winding up. Additionally, the Board reviewed exchange notices regarding delayed compliance under Regulation 29 for the quarter ended 30th Jun'26 due to procedural calculation oversights. Fines totaling INR 11,800 each to NSE and BSE have been duly settled within prescribed timelines.
Voting Results and Scrutiniser''s Report for 22nd AGM of the Company for FY 2026.
Annual General Meeting · 30 Sept 2026, 1:19 am
Proceeding of the 22nd Annual General Meeting of the Company held on Friday, September 25, 2026.
Annual General Meeting · 25 Sept 2026, 7:31 pm
Intimation of Schedule of Analyst/ Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 to be held on 29th September, 2026.
Intimation · 24 Sept 2026, 12:16 am
Laxmi Dental Schedules Non-Deal Roadshow in Mumbai on 29th Sep'26 Laxmi Dental Limited announced that company officials will participate in a Non-Deal Roadshow (NDR) organized by Motilal Oswal Financial Services on 29th Sep'26 from 9:00 AM onwards in Mumbai. The event will involve 1x1 and group investor meetings. Management confirmed that discussions will rely strictly on publicly available information, with no unpublished price-sensitive information (UPSI) to be shared during the interactions.
Intimation of Schedule of Analyst/ Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 to be held on 28th September, 2026.
Intimation · 24 Sept 2026, 12:10 am
Laxmi Dental to Participate in Motilal Oswal Non-Deal Roadshow Laxmi Dental Limited announced that company officials will participate in a Non-Deal Roadshow (NDR) organized by Motilal Oswal Financial Services in Mumbai on 28th Sep'26, starting at 9:00 AM. The interactions will involve 1x1 and group meetings with institutional investors and analysts. Discussions will be restricted to publicly available information, and no unpublished price-sensitive information will be shared.
National Stock Exchange of India Limited (''NSE'') and BSE Limited (''BSE'') have issued their respective approvals for listing of further issue of 7,911 Equity Shares of face value of ....
Others (Uncategorized) · 18 Sept 2026, 5:32 pm
Laxmi Dental Secures Listing Approval for 7,911 ESOP Shares on NSE and BSE NSE and BSE have approved the listing and trading of 7,911 equity shares of face value Rs. 2 each of Laxmi Dental Limited, allotted under the Laxmi Dental Employee Stock Option Scheme 2024. The shares (distinctive numbers 55021510 to 55029420) are admitted to dealings on both exchanges effective 18th Sep'26, following formal approval letters issued on 17th Sep'26.
Intimation of Schedule of Analyst/ Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015.
Intimation · 05 Sept 2026, 12:13 am
Laxmi Dental Schedules Analyst and Institutional Investor Group Meeting Laxmi Dental Limited has scheduled an in-person group interaction with analysts and institutional investors on 9th Sep'26, starting at 10:00 AM at its manufacturing facilities located in the Mumbai Metropolitan Region. The company confirmed that discussions will rely strictly on publicly available information, and no unpublished price-sensitive information (UPSI) will be shared during the meetings.
Notice convening the 22nd Annual General Meeting ('AGM') and submission of Annual Report for Financial Year 2025-26
Others (Uncategorized) · 04 Sept 2026, 2:50 am
Intimation of 22nd Annual General Meeting ('AGM') of the Company scheduled to be held on Friday, September 25, 2026.
Annual General Meeting · 04 Sept 2026, 2:34 am